Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF Accounts Payable

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF (GNMX) currently reports a accounts payable of $9M as of September 2019. That compares with $10M in the prior-year period — down 11.3% year over year. Use the charts on this page to explore Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's accounts payable history and peer comparisons.

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's accounts payable decreased from $10M to $9M — a 11.3% year-over-year decrease (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF reported $9M in accounts payable as of September 2019. That compares with $10M in the prior-year period — down 11.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF, and consider following GNMX for alerts when major investors trade the stock.